• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 42866
Device Problems Inaccurate Flow Rate (1249); Mechanics Altered (2984)
Patient Problems Vomiting (2144); Therapeutic Response, Decreased (2271); Ambulation Difficulties (2544)
Event Date 10/31/2017
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that prior to the implant of the shunt, the patient experienced syncope and was hospitalized in early (b)(6) 2012.A few days after the syncope, they underwent tumor resection with a suboccipital approach.The patient had a ventriculoatrial shunt installed by the end of (b)(6) 2012.A few years later, in late (b)(6) 2016, the patient¿s brain tumor recurred.They underwent tumor resection in early (b)(6) and the pressure level (pl) setting of the valve was set to 0.5.The patient experienced vomiting, unstable walking, and was unresponsive in (b)(6) 2017.The patient was admitted with the pl setting still at 0.5.It was stated that 200-300 ml of cerebrospinal fluid was drained from the patient and their symptoms improved.In late (b)(6) , the patient had exploratory surgery and after the operation was better, however would soon regress.It was noted the patient repeatedly had mris done following surgery and could not reach the same drainage effect as experienced prior to the mri.The doctor questioned whether the valve was damaged.The shunt was removed and replaced.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
The returned valve was patent.It met the requirements for siphon, and pre-implantation testing.The valve did not meet the requirements for reflux and pressure-flow testing.There was proteinaceous debris observed within the interior and exterior of the valve.Debris within the valve may hold pressure-flow controlling mechanisms open resulting in fluid reflux and affecting the flow of fluid through the valve.Instructions for use (ifu) that accompany the device caution that ¿shunt obstruction may occur in any of the components of the shunt system.The system may become occluded internally due to tissue fragments, blood clots, tumor cell aggregates, bacterial colonization, or other debris.¿ the returned valve also did not meet the requirements for leak due to multiple tears in the top of the reservoir.It is unknown how or when this damage occurred.The ifu caution that ¿improper use of instruments in the handling or implantation of shunt products may result in the cutting, slitting, or crushing of components.¿ the ifu also caution that ¿care should be taken in handling the valves as silicone has a low cut and tear resistance.All valves are 100% tested at the time of manufacture.Upon review of the analysis results, it was determined that eval code conclusion 92 no longer applies.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a health care provider (hcp) via a manufacturer representative (rep).It was confirmed that the valve settings were changed after the mri.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATA II VALVE, REGULAR
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer (Section G)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer Contact
stacy ruemping
7000 central avenue ne rcw215
minneapolis, MN 55432
7635260594
MDR Report Key7064344
MDR Text Key93113664
Report Number2021898-2017-00609
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K042465
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/28/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/28/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2015
Device Model Number42866
Device Catalogue Number42866
Device Lot NumberD23189
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/30/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/22/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/23/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age24 YR
-
-